142 related articles for article (PubMed ID: 3489999)
1. [Immunoglobulins and insulin-binding capacity of T lymphocytes in diabetes mellitus types I and II].
Antsiferov MB; Arbuzova MI; Perelygina AA; Starosel'tseva LK
Sov Med; 1986; (7):25-8. PubMed ID: 3489999
[No Abstract] [Full Text] [Related]
2. [Effects of xenotransplantation of pancreatic islet cells on the immune status of patients with diabetes mellitus].
Morozov IuI; Kirdeĭ EG; Kim AIu
Klin Med (Mosk); 1995; 73(2):32-4. PubMed ID: 7609413
[TBL] [Abstract][Full Text] [Related]
3. [Insulin receptor interactions and metabolic effects of "essential" phospholipids in diabetes mellitus].
Mikaelian NP; Kniazev IuA; Maksina AG; Mikaelian EP
Biull Eksp Biol Med; 1994 Oct; 118(10):388-92. PubMed ID: 7865816
[No Abstract] [Full Text] [Related]
4. [Quantitative changes of the blood serum immunoglobulins in patients with diabetes mellitus types I and II and microangiopathy detected by morphologic study].
Saltykov BB; Velikov VK; Tarasov VK; Pershin BB; Kuz'min SN; Shubina OI; Frolova AI; Zelenchuk NM; Shepkova TP
Ter Arkh; 1990; 62(4):111-4. PubMed ID: 2392748
[TBL] [Abstract][Full Text] [Related]
5. The T lymphocyte insulin receptor in diabetes and obesity: an intrinsic binding defect.
Helderman JH; Raskin P
Diabetes; 1980 Jul; 29(7):551-7. PubMed ID: 6991340
[No Abstract] [Full Text] [Related]
6. T-lymphocyte subsets and their cytotoxic capacity in patients with type I and type II diabetes mellitus.
Horváth M; Varsányi M; Jovanovich N; Rózsás Z; Balázsi I
Allergol Immunopathol (Madr); 1986; 14(5):399-405. PubMed ID: 3492131
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
[TBL] [Abstract][Full Text] [Related]
8. [Heterogeneity of diabetes mellitus].
Asfandiiarova NS; Kolcheva NG; Shatrova IV
Ter Arkh; 1999; 71(12):49-52. PubMed ID: 10647203
[TBL] [Abstract][Full Text] [Related]
9. Similar alterations of lymphocyte subpopulations in type I and type II diabetes.
Spooren PF; Vermes I; Soons JW
Neth J Med; 1993 Jun; 42(5-6):163-7. PubMed ID: 8377873
[TBL] [Abstract][Full Text] [Related]
10. Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions.
Daoud AK; Tayyar MA; Fouda IM; Harfeil NA
J Immunotoxicol; 2009 Mar; 6(1):36-41. PubMed ID: 19519161
[TBL] [Abstract][Full Text] [Related]
11. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes.
McInerney MF; Flynn JC; Goldblatt PJ; Najjar SM; Sherwin RS; Janeway CA
J Immunol; 1996 Oct; 157(8):3716-26. PubMed ID: 8871675
[TBL] [Abstract][Full Text] [Related]
12. [Complement (C3) receptor dependent monocyte recognition in uncompensated diabetes mellitus types I and II].
Gómez Rodríguez F; Ruiz Alcantarilla P; Zamora Madaria E
Rev Clin Esp; 1986 Sep; 179(4):167-71. PubMed ID: 3532232
[No Abstract] [Full Text] [Related]
13. [Pyruvate kinase activity as a marker of erythrocyte age increases the reliability of the method of determining insulin binding to membrane receptors].
Klimes I; Zórad S; Svábová E; Ficková M; Sorocinová E; Macho L
Vnitr Lek; 1987 Jun; 33(6):454-63. PubMed ID: 3310385
[No Abstract] [Full Text] [Related]
14. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus.
Jackson RA; Morris MA; Haynes BF; Eisenbarth GS
N Engl J Med; 1982 Apr; 306(13):785-8. PubMed ID: 7038489
[No Abstract] [Full Text] [Related]
15. [Insulin resistance, obesity and diabetes. Mechanism of development and their mutual relations].
Klimes I; Ficková M
Vnitr Lek; 1984 Dec; 30(12):1206-18. PubMed ID: 6395481
[No Abstract] [Full Text] [Related]
16. [Insulin receptor and postreceptor disorders: significance for the development and therapy of carbohydrate metabolic disorders].
Schernthaner G; Prager R
Acta Med Austriaca; 1984; 11(3-4):70-8. PubMed ID: 6382903
[TBL] [Abstract][Full Text] [Related]
17. [Immunological aspects of wound healing in patients with diabetes mellitus].
Kim AIu; Morozov IuI; Kirdeĭ EG
Klin Med (Mosk); 1994; 72(6):48-50. PubMed ID: 7898011
[TBL] [Abstract][Full Text] [Related]
18. [Insulin resistance in type 2 diabetes. Receptor and post-receptor aspects].
Purrello F; Trischitta V; Vigneri R
Minerva Endocrinol; 1984; 9(2):221-8. PubMed ID: 6390135
[No Abstract] [Full Text] [Related]
19. [Insulin-binding activity of lymphocytes bearing Fcgamma-receptors in pregnant women with diabetes mellitus].
Zhumagalieva GD; Mikaelian NP; Skriabina EG; Petrukhin VA; Kniazev IuA; Cheredeev AN
Biull Eksp Biol Med; 1999 Feb; 127(2):230-3. PubMed ID: 10095965
[No Abstract] [Full Text] [Related]
20. Immunity in diabetes mellitus.
Narang NK; Gupta RC; Singh N
J Assoc Physicians India; 1989 Sep; 37(9):614. PubMed ID: 2632568
[No Abstract] [Full Text] [Related]
[Next] [New Search]
